| ［1］ |
Mudduluru BM, Shah S, Shamah S, et al. TNF⁃alpha antagonist induced lupus on three different agents［J］. Postgrad Med, 2017,129（2）:304⁃306. doi: 10.1080/00325481.2017.1249266.
|
| ［2］ |
Williams VL, Cohen PR. TNF alpha antagonist⁃induced lupus⁃like syndrome: report and review of the literature with implications for treatment with alternative TNF alpha antagonists［J］. Dermatol, 2011,50（5）:619⁃625. doi: 10.1111/j.1365⁃4632. 2011.04871.x.
|
| ［3］ |
Katz U, Zandman⁃Goddard G. Drug⁃induced lupus: an update［J］. Autoimmun Rev, 2010,10（1）:46⁃50. doi: 10.1016/j.autrev.2010.07. 005.
|
| ［4］ |
Lis⁃Swięty A, Brzezińska⁃Wcisło L, Widuchowska M, et al. Subacute cutaneous lupus erythematosus in the course of rheumatoid arthritis: a relationship with TNF⁃α antagonists and rituximab therapy?［J］. Immunopharmacol Immunotoxicol, 2013,35（3）:443⁃446. doi: 10.3109/08923973.2013.780077.
|
| ［5］ |
Bazsó A, Sevcic K, Orbán I, et al. Overlapping juvenile idiopathic arthritis and systemic lupus erythematosus: a case report［J］. Rheumatol Int, 2011,31（5）:695⁃698. doi: 10.1007/s00296⁃010⁃1594⁃z.
|
